F2 and blood coagulation disease: Moreover, we observed strong signals of higher frequency of reporting coagulation dysfunction events associated with tigecycline in the events of thrombocytopenia, hypofibrinogenaemia, coagulopathy, activated partial thromboplastin time prolonged, international normalised ratio increased, and prothrombin time prolonged.